Innate immune activation of NFκB and its antagonism by poxviruses

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 611-620

  Brady, Gareth ^a   Bowie, Andrew G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

IL 1; NF B; Poxvirus; TNF; Viral immune evasion

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1; NUCLEIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR; CYTOKINE; PATTERN RECOGNITION RECEPTOR; PHOSPHOTRANSFERASE;

ADAPTIVE IMMUNITY; CHORDOPOXVIRINAE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOSOL; DENDRITIC CELL; HUMAN; IMMUNE EVASION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; REVIEW; VACCINIA VIRUS; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; POXVIRIDAE; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; NF-KAPPA B; PHOSPHOTRANSFERASES; POXVIRIDAE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 84908318172     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.07.004     Document Type: Review

References (100)

1. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. The genome of canarypox virus. J Virol 2004, 78:353-366.
2. Brunetti C.R., Amano H., Ueda Y., Qin J., Miyamura T., Suzuki T., et al. Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus. J Virol 2003, 77:13335-13347.
3. Xing K., Deng R., Wang J., Feng J., Huang M., Wang X. Genome-based phylogeny of poxvirus. Intervirology 2006, 49:207-214.
4. Haller S.L., Peng C., McFadden G., Rothenburg S. Poxviruses and the evolution of host range and virulence. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 2014, 21:15-40.
5. McFadden G. Poxvirus tropism. Nat Rev Microbiol 2005, 3:201-213.
6. Moss B. Poxvirus entry and membrane fusion. Virology 2006, 344:48-54.
7. Chen X., Anstey A.V., Bugert J.J. Molluscum contagiosum virus infection. Lancet Infect Dis 2013, 13:877-888.
8. Lefkowitz E.J., Wang C., Upton C. Poxviruses: past, present and future. Virus Res 2006, 117:105-118.
9. Ball L.A. High-frequency homologous recombination in vaccinia virus DNA. J Virol 1987, 61:1788-1795.
10. Esteban D.J., Hutchinson A.P. Genes in the terminal regions of orthopoxvirus genomes experience adaptive molecular evolution. BMC Genomics 2011, 12:261.
11. Elde N.C., Child S.J., Eickbush M.T., Kitzman J.O., Rogers K.S., Shendure J., et al. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 2012, 150:831-841.
12. Tsai S.Y., Segovia J.A., Chang T.H., Morris I.R., Berton M.T., Tessier P.A., et al. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog 2014, 10:e1003848.
13. Kim T.K., Maniatis T. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol Cell 1997, 1:119-129.
14. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17:6660-6669.
15. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009, 1:a001651.
16. Friedman R., Hughes A.L. Molecular evolution of the NF-kappaB signaling system. Immunogenetics 2002, 53:964-974.
17. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663.
18. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
19. Beinke S., Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004, 382:393-409.
20. Gonzalez J.M., Esteban M. A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J 2010, 7:59.
21. DiPerna G., Stack J., Bowie A.G., Boyd A., Kotwal G., Zhang Z., et al. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 2004, 279:36570-36578.
22. Ember S.W., Ren H., Ferguson B.J., Smith G.L. Vaccinia virus protein C4 inhibits NF-kappaB activation and promotes virus virulence. J Gen Virol 2012, 93:2098-2108.
23. Mansur D.S., Maluquer de Motes C., Unterholzner L., Sumner R.P., Ferguson B.J., Ren H., et al. Poxvirus targeting of E3 ligase beta-TrCP by molecular mimicry: a mechanism to inhibit NF-kappaB activation and promote immune evasion and virulence. PLoS Pathog 2013, 9:e1003183.
24. Smith G.L., Benfield C.T., Maluquer de Motes C., Mazzon M., Ember S.W., Ferguson B.J., et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013, 94:2367-2392.
25. Sonnberg S., Fleming S.B., Mercer A.A. Phylogenetic analysis of the large family of poxvirus ankyrin-repeat proteins reveals orthologue groups within and across chordopoxvirus genera. J Gen Virol 2011, 92:2596-2607.
26. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998, 95:759-770.
27. Jacobs M.D., Harrison S.C. Structure of an IkappaBalpha/NF-kappaB complex. Cell 1998, 95:749-758.
28. Shisler J.L., Jin X.L. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 2004, 78:3553-3560.
29. Chang S.J., Hsiao J.C., Sonnberg S., Chiang C.T., Yang M.H., Tzou D.L., et al. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function. J Virol 2009, 83:4140-4152.
30. Alzhanova D., Fruh K. Modulation of the host immune response by cowpox virus. Microb Infect Inst Pasteur 2010, 12:900-909.
31. Camus-Bouclainville C., Fiette L., Bouchiha S., Pignolet B., Counor D., Filipe C., et al. A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J Virol 2004, 78:2510-2516.
32. Mohamed M.R., Rahman M.M., Lanchbury J.S., Shattuck D., Neff C., Dufford M., et al. Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci USA 2009, 106:9045-9050.
33. Rahman M.M., Mohamed M.R., Kim M., Smallwood S., McFadden G. Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013. PLoS Pathog 2009, 5:e1000635.
34. Diel D.G., Delhon G., Luo S., Flores E.F., Rock D.L. A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus. J Virol 2010, 84:3962-3973.
35. Ning Z., Zheng Z., Hao W., Duan C., Li W., Wang Y., et al. The N terminus of orf virus-encoded protein 002 inhibits acetylation of NF-kappaB p65 by preventing Ser(276) phosphorylation. PLOS ONE 2013, 8:e58854.
36. Diel D.G., Luo S., Delhon G., Peng Y., Flores E.F., Rock D.L. Orf virus ORFV121 encodes a novel inhibitor of NF-kappaB that contributes to virus virulence. J Virol 2011, 85:2037-2049.
37. Shisler J.L. Viral and cellular FLICE-inhibitory proteins: a comparison of their roles in regulating intrinsic immune responses. J Virol 2014, 88:6539-6541.
38. O'Neill L.A., Golenbock D., Bowie A.G. The history of toll-like receptors - redefining innate immunity. Nat Rev Immunol 2013, 13:453-460.
39. Hutchens M., Luker K.E., Sottile P., Sonstein J., Lukacs N.W., Nunez G., et al. TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol 2008, 180:483-491.
40. Hutchens M.A., Luker K.E., Sonstein J., Nunez G., Curtis J.L., Luker G.D. Protective effect of toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog 2008, 4:e1000153.
41. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
42. Georgel P., Jiang Z., Kunz S., Janssen E., Mols J., Hoebe K., et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral toll-like receptor 4-dependent pathway. Virology 2007, 362:304-313.
43. Shirey K.A., Lai W., Scott A.J., Lipsky M., Mistry P., Pletneva L.M., et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 2013, 497:498-502.
44. O'Gorman W.E., Sampath P., Simonds E.F., Sikorski R., O'Malley M., Krutzik P.O., et al. Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses. Cell Host Microbe 2010, 8:174-185.
45. Davies M.L., Sei J.J., Siciliano N.A., Xu R.H., Roscoe F., Sigal L.J., et al. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve toll-like receptor 2. J Virol 2014, 88:3557-3567.
46. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
47. Cao H., Dai P., Wang W., Li H., Yuan J., Wang F., et al. Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain. PLOS ONE 2012, 7:e36823.
48. Martinez J., Huang X., Yang Y. Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci USA 2010, 107:6442-6447.
49. Samuelsson C., Hausmann J., Lauterbach H., Schmidt M., Akira S., Wagner H., et al. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Investig 2008, 118:1776-1784.
50. Dai P., Cao H., Merghoub T., Avogadri F., Wang W., Parikh T., et al. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway. J Virol 2011, 85:10814-10825.
51. Kawai K., Shimura H., Minagawa M., Ito A., Tomiyama K., Ito M. Expression of functional toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002, 30:185-194.
52. Ku J.K., Kwon H.J., Kim M.Y., Kang H., Song P.I., Armstrong C.A., et al. Expression of toll-like receptors in verruca and Molluscum contagiosum. J Kor Med Sci 2008, 23:307-314.
53. Seleit I., Bakry O.A., Abdou A.G., Dawoud N.M. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis. Ann Diagn Pathol 2014, 18:117-124.
54. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci USA 2000, 97:10162-10167.
55. Fedosyuk S., Grishkovskaya I., de Almeida Ribeiro E., Skern T. Characterization and structure of the vaccinia virus NF-kappaB antagonist A46. J Biol Chem 2014, 289:3749-3762.
56. Graham S.C., Bahar M.W., Cooray S., Chen R.A., Whalen D.M., Abrescia N.G., et al. Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 2008, 4:e1000128.
57. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., et al. The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J Exp Med 2003, 197:343-351.
58. Keating S.E., Maloney G.M., Moran E.M., Bowie A.G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 2007, 282:33435-33443.
59. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., et al. Vaccinia virus protein A46R targets multiple toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 2005, 201:1007-1018.
60. Stack J., Bowie A.G. Poxviral protein A46 antagonizes toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor: adaptor interactions. J Biol Chem 2012, 287:22672-22682.
61. Lysakova-Devine T., Keogh B., Harrington B., Nagpal K., Halle A., Golenbock D.T., et al. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol 2010, 185:4261-4271.
62. Schroder M., Baran M., Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J 2008, 27:2147-2157.
63. Chen R.A., Ryzhakov G., Cooray S., Randow F., Smith G.L. Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 2008, 4:e22.
64. Aravalli R.N., Hu S., Lokensgard J.R. Inhibition of toll-like receptor signaling in primary murine microglia. J Neuroimmune Pharmacol: Off J Soc Neuroimmune Pharmacol 2008, 3:5-11.
65. Laidlaw S.M., Robey R., Davies M., Giotis E.S., Ross C., Buttigieg K., et al. Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon. J Virol 2013, 87:5041-5052.
66. Brandt T.A., Jacobs B.L. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 2001, 75:850-856.
67. Waibler Z., Anzaghe M., Ludwig H., Akira S., Weiss S., Sutter G., et al. Modified vaccinia virus Ankara induces toll-like receptor-independent type I interferon responses. J Virol 2007, 81:12102-12110.
68. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
69. Wang F., Gao X., Barrett J.W., Shao Q., Bartee E., Mohamed M.R., et al. RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog 2008, 4:e1000099.
70. Myskiw C., Arsenio J., Booy E.P., Hammett C., Deschambault Y., Gibson S.B., et al. RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis. Virology 2011, 413:183-193.
71. Pichlmair A., Schulz O., Tan C.P., Rehwinkel J., Kato H., Takeuchi O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
72. Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009, 5:e1000480.
73. Pollpeter D., Komuro A., Barber G.N., Horvath C.M. Impaired cellular responses to cytosolic DNA or infection with Listeria monocytogenes and vaccinia virus in the absence of the murine LGP2 protein. PLoS ONE 2011, 6:e18842.
74. Guerra S., Najera J.L., Gonzalez J.M., Lopez-Fernandez L.A., Climent N., Gatell J.M., et al. Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. J Virol 2007, 81:8707-8721.
75. Lemos de Matos A., McFadden G., Esteves P.J. Evolution of viral sensing RIG-I-like receptor genes in Leporidae genera Oryctolagus, Sylvilagus, and Lepus. Immunogenetics 2014, 66:43-52.
76. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80:5059-5064.
77. Deng L., Dai P., Parikh T., Cao H., Bhoj V., Sun Q., et al. Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3. J Virol 2008, 82:10735-10746.
78. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
79. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
80. Valentine R., Smith G.L. Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J Gen Virol 2010, 91:2221-2229.
81. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
82. Burdette D.L., Vance R.E. STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 2013, 14:19-26.
83. Cai X., Chiu Y.H., Chen Z.J. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 2014, 54:289-296.
84. Ablasser A., Goldeck M., Cavlar T., Deimling T., Witte G., Rohl I., et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 2013, 498:380-384.
85. Ablasser A., Schmid-Burgk J.L., Hemmerling I., Horvath G.L., Schmidt T., Latz E., et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 2013, 503:530-534.
86. Dai P., Wang W., Cao H., Avogadri F., Dai L., Drexler I., et al. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog 2014, 10:e1003989.
87. Abe T., Barber G.N. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1. J Virol 2014, 88:5328-5341.
88. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife 2012, 1:e00047.
89. Peters N.E., Ferguson B.J., Mazzon M., Fahy A.S., Krysztofinska E., Arribas-Bosacoma R., et al. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 2013, 9:e1003649.
90. Roth S., Rottach A., Lotz-Havla A.S., Laux V., Muschaweckh A., Gersting S.W., et al. Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1beta production. Nat Immunol 2014, 15:538-545.
91. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
92. Jin T., Perry A., Jiang J., Smith P., Curry J.A., Unterholzner L., et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 2012, 36:561-571.
93. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 1992, 69:597-604.
94. Gerlic M., Faustin B., Postigo A., Yu E.C., Proell M., Gombosuren N., et al. Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci USA 2013, 110:7808-7813.
95. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
96. Silke J. The regulation of TNF signalling: what a tangled web we weave. Curr Opin Immunol 2011, 23:620-626.
97. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., et al. Poxviruses and immune evasion. Annu Rev Immunol 2003, 21:377-423.
98. Gileva I.P., Nepomnyashchikh T.S., Antonets D.V., Lebedev L.R., Kochneva G.V., Grazhdantseva A.V., et al. Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. Biochim Biophys Acta 2006, 1764:1710-1718.
99. Brunetti C.R., Paulose-Murphy M., Singh R., Qin J., Barrett J.W., Tardivel A., et al. A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc Natl Acad Sci USA 2003, 100:4831-4836.
100. Sumner R.P., Maluquer de Motes C., Veyer D.L., Smith G.L. Vaccinia virus inhibits NF-kappaB-dependent gene expression downstream of p65 translocation. J Virol 2014, 88:3092-3102.